(DNOV) FT Cboe Vest U.S. Equity - Overview
Etf: FLEX, Options, S&P500, ETF, Non-Diversified
| Risk 5d forecast | |
|---|---|
| Volatility | 7.60% |
| Relative Tail Risk | 1.12% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.86 |
| Alpha | 3.20 |
| Character TTM | |
|---|---|
| Beta | 0.471 |
| Beta Downside | 0.498 |
| Drawdowns 3y | |
|---|---|
| Max DD | 9.98% |
| CAGR/Max DD | 1.33 |
Description: DNOV FT Cboe Vest U.S. Equity January 25, 2026
FT Cboe Vest U.S. Equity Deep Buffer ETF – November (BATS: DNOV) is a non-diversified, defined-outcome ETF that, under normal market conditions, allocates virtually all of its capital to FLEX Options on the SPDR S&P 500 ETF (SPY). These customized exchange-traded options let the fund set its own strike, style and expiry, creating a “deep buffer” that absorbs losses up to a predefined threshold while capping upside at the option premium received.
As of 24 Jan 2026, the S&P 500 has risen 4.2% year-to-date, while the CBOE Volatility Index (VIX) sits at 15.8, indicating relatively low implied volatility and thus tighter option premiums. The fund’s November buffer is set at roughly 8% below the SPY price, meaning that, historically, an 8% market decline would be absorbed before any equity loss is realized. Recent macro data show the Fed’s policy rate steady at 5.25%, and core PCE inflation running at 2.1% YoY, both supporting a moderate equity environment that favors premium-selling strategies.
Overview
Ticker Symbol: DNOV
Type: ETF
Country of Origin: USA
ETF Category: Defined Outcome
For a deeper, data-driven assessment of DNOV’s risk-return trade-off, consult the ValueRay analytics platform.
What is the price of DNOV shares?
Over the past week, the price has changed by -0.02%, over one month by +0.22%, over three months by +4.02% and over the past year by +12.45%.
Is DNOV a buy, sell or hold?
What are the forecasts/targets for the DNOV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 54.7 | 11.3% |
DNOV Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 381.2m USD (381.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 381.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 381.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.65% (E(381.2m)/V(381.2m) * Re(7.65%) + (debt-free company))
Discount Rate = 7.65% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)